HR 3493 · Global Fairness in Drug Pricing Act
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced
- May 19, 2025
- Latest action
- May 19, 2025
- Sponsor
- Rep. Ro Khanna [D-CA-17]
- Policy area
- Health
- Cosponsors
- 7
Recent actions
- May 19, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- May 19, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- May 19, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- May 19, 2025 Introduced in House
- May 19, 2025 Introduced in House
Votes
No recorded votes are available for this bill.